US Patent Number
Cytisine-linked isoflavonoids, or pharmaceutically acceptable salts thereof or pharmaceutically acceptable compositions thereof, are useful for the treatment of conditions in which cells have a reliance on peroxisomal HSD17B4 to degrade very long chain fatty acids and provide necessary energy for cell proliferation, such as is seen in colorectal cancer and prostate cancer, for example.
University of Kentucky Research Foundation, Lexington, KY (US)
Liu, Chunming; Watt, David S.; Frasinyuk, Mykhaylo S.; Sviripa, Vitaliy M.; Zhang, Wen; and Bondarenko, Svitlana P., "Cytisine-Linked Isoflavonoid Antineoplastic Agents for the Treatment of Cancer" (2019). Markey Cancer Center Faculty Patents. 5.